FDA Outlaws HormonesFDA Outlaws Compounded Hormones
WHAT DO WE KNOW? The FDA claims that the NASEM report, which recommends restrictions on compounded hormone therapy, is “independent” and “comprehensive,” but a third-party analysis of the NASEM report shows it to be compromised by conflicts of interest, and bad science. The analysis shows that the agency exerted inappropriate influence and bias in almost every phase of the commissioned report, even recommending study committee appointees who had NO EXPERTISE in prescribing or compounding hormones. CLICK HERE TO READ MORE…..
FOR FURTHER EDUCATION ON THE TOPIC, READ: Safety and efficacy of compounded bioidentical hormone therapy (cBHT) in perimenopausal and postmenopausal women: a systematic review and meta-analysis of randomized controlled trials